Persistent, Unexplained Leukocytosis Is a Paraneoplastic Syndrome Associated with a Poor Prognosis in Patients with Urothelial Carcinoma

Clinical Genitourinary Cancer

Volumn 13, Issue 4, 2015, Pages e253-e258

  Izard, Jason P ^a   Gore, John L ^b   Mostaghel, Elahe A ^b   Wright, Jonathan L ^b   Yu, Evan Y ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Bladder cancer; Laboratory markers; Prognostic markers; White blood cell count

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; GEMCITABINE; GROWTH FACTOR; METHOTREXATE; PEMETREXED; STEROID; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL STUDY; CYSTECTOMY; DISEASE ASSOCIATION; DISEASE COURSE; EOSINOPHIL COUNT; FEMALE; HISTOLOGY; HUMAN; HYPERCALCEMIA; HYPERURICEMIA; HYPOPHOSPHATEMIA; INCIDENCE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUTROPHIL COUNT; NEUTROPHILIA; OUTCOME ASSESSMENT; PARANEOPLASTIC LEUKOCYTOSIS; PARANEOPLASTIC SYNDROME; STEROID THERAPY; SYSTEMIC THERAPY; THROMBOCYTOSIS; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME; CARCINOMA, TRANSITIONAL CELL; COMPLICATION; DRUG EFFECTS; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; TUMOR INVASION; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; LEUKOCYTOSIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PARANEOPLASTIC SYNDROMES; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 84936985294     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2015.02.008     Document Type: Article

References (30)

1. I. Kasuga, S. Makino, H. Kiyokawa, H. Katoh, Y. Ebihara, and K. Ohyashiki Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma Cancer 92 2001 2399 2405
2. J.M. Granger, and D.P. Kontoyiannis Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study Cancer 115 2009 3919 3923
3. L.C. McKee Jr. Excess leukocytosis (leukemoid reactions) associated with malignant diseases South Med J 78 1985 1475 1482
4. B. Schniewind, M. Christgen, A. Hauschild, R. Kurdow, H. Kalthoff, and H.J. Klomp Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell line Cancer Biol Ther 4 2005 23 27
5. H.S. Nimieri, S.N. Makoni, F.H. Madziwa, and D.S. Nemiary Leukemoid reaction response to chemotherapy and radiotherapy in a patient with cervical carcinoma Ann Hematol 82 2003 316 317
6. S. Saussez, P. Heimann, and L. Vandevelde Undifferentiated carcinoma of the nasopharynx and leukemoid reaction: report of case with literature review J Laryngol Otol 111 1997 66 69
7. A. Ferrer, F. Cervantes, J.C. Hernandez-Boluda, A. Alvarez, and E. Montserrat Leukemoid reaction preceding the diagnosis of colorectal carcinoma by four years Haematologica 84 1999 671 672
8. J.W. Dukes, and L.M. Tierney Jr. Paraneoplastic leukemoid reaction as marker for transitional cell carcinoma recurrence Urology 73 2009 928.e17 928.e19
9. K. Hirasawa, T. Kitamura, T. Oka, and H. Matsushita Bladder tumor producing granulocyte colony-stimulating factor and parathyroid hormone related protein J Urol 167 2002 2130
10. N. Ito, T. Matsuda, Y. Kakehi, E. Takeuchi, T. Takahashi, and O. Yoshida Bladder cancer producing granulocyte colony-stimulating factor N Engl J Med 323 1990 1709 1710
11. T. Kamai, T. Toma, H. Masuda, and D. Ishiwata Simultaneous production of parathyroid hormone-related protein and granulocyte colony-stimulating factor in renal pelvic cancer J Natl Cancer Inst 90 1998 249 250
12. S. Kitayama, Y. Fujii, and K. Kihara Urothelial cancer producing granulocyte colony-stimulating factor: possible induction of splenomegaly Urology 63 2004 377 378
13. S.N. McRae, R. Gilbert, F.D. Deamant, and J.H. Reese Poorly differentiated carcinoma of bladder producing granulocyte colony-stimulating factor and parathyroid hormone related protein J Urol 165 2001 527 528
14. F.A. Perez, C.L. Fligner, and E.Y. Yu Rapid clinical deterioration and leukemoid reaction after treatment of urothelial carcinoma of the bladder: possible effect of granulocyte colony-stimulating factor J Clin Oncol 27 2009 e215 e217
15. H. Satoh, Y. Abe, Y. Katoh, Y. Komine, M. Nakamura, and N. Tamaoki Bladder carcinoma producing granulocyte colony-stimulating factor: a case report J Urol 149 1993 843 845
16. H. von der Maase, L. Sengelov, and J.T. Roberts Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 2005 4602 4608
17. K. Welte, E. Platzer, and L. Lu Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor Proc Natl Acad Sci U S A 82 1985 1526 1530
18. T. Yamanaka, S. Matsumoto, S. Teramukai, R. Ishiwata, Y. Nagai, and M. Fukushima The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer Oncology 73 2007 215 220
19. W. Chua, K.A. Charles, V.E. Baracos, and S.J. Clarke Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer Br J Cancer 104 2011 1288 1295
20. B. Azab, V.R. Bhatt, and J. Phookan Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients Ann Surg Oncol 19 2012 217 224
21. B.R. Viers, S.A. Boorjian, and I. Frank Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy Eur Urol 66 2014 1157 1164
22. T. Gondo, J. Nakashima, and Y. Ohno Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy Urology 79 2012 1085 1091
23. T. Hermanns, B. Bhindi, and Y. Wei Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder Br J Cancer 111 2014 444 451
24. L.S. Krane, K.A. Richards, A.K. Kader, R. Davis, K.C. Balaji, and A.K. Hemal Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy J Endourol 27 2013 1046 1050
25. Y.H. Kusumanto, W.A. Dam, G.A. Hospers, C. Meijer, and N.H. Mulder Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor Angiogenesis 6 2003 283 287
26. J.P. Crew, T. O'Brien, and M. Bradburn Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer Cancer Res 57 1997 5281 5285
27. M. Tachibana, A. Miyakawa, and H. Tazaki Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor Cancer Res 55 1995 3438 3443
28. K.M. Zsebo, A.M. Cohen, and D.C. Murdock Recombinant human granulocyte colony stimulating factor: molecular and biological characterization Immunobiology 172 1986 175 184
29. S. Vaidyanathan, P. Mansour, and M. Ueno Problems in early diagnosis of bladder cancer in a spinal cord injury patient: report of a case of simultaneous production of granulocyte colony stimulating factor and parathyroid hormone-related protein by squamous cell carcinoma of urinary bladder BMC Urol 2 2002 8
30. P. Papaldo, G. Ferretti, and S. Di Cosimo Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide? J Clin Oncol 24 2006 3048 3055